SBMF Online Payment ▶

test directorySearch Results

Click here to search again.

Test Name:
Drug Screen without Volatiles, Blood


  • SBMF No:
    31162
  • Performance Lab Name:
    Toxicology
  • Test Mnemonic:
    SDS-
  • ABN:
    May be required – Medical Necessity
  • CPT Code:
    80100; 80101x5
    Medicare: G0431; G0434
  • LOINC Code:
    39111-0; 15401-3
  • Test Includes:
    acetaminophen, alprazolam, amitriptyline, amphetamine, amobarbital, benzodiazepine class, brompheniramine, bupropion, butabarbital, butalbital, carbamazepine, carisoprodol, chlordiazepoxide, chlorpheniramine, clomipramine, clonazepam, clorazepate (as nordiazepam), cocaine metabolite, codeine, cyclobenzaprine, desalkylflurazepam, dextromethorphan, diazepam, dihydrocodeine, diphenydramine, doxepin, doxylamine, ephedrine/pseudoephedrine, ethosuximide, flurazepam, fluoxetine, glutehimide, hydrocodone, hydromorphone, hydroxyzine, ibuprofen, imipramine, lidocaine, lorazepam, MDA, MDMA, meperidine, meprobamate, methadone, methamphetamine, methaqualone, metoprolol, morphine, NAPA, naproxen, nordiazepam, nortriptyline, opiate class, oxycodone, pentazocine, pentobarbital, phencyclidine, phenobarbital, phentermine, phenylpropanolamine, phenytoin, primidone, procainamide, promethazine, propoxyphene, pseudophedrine/ephedrine, salicylate, secobarbital, sertraline, temazepam, THC (marijuana metabolite), theophylline, thioridazine, tramadol, trazodone, trimipramine, tripelennamine, venlafaxine, verapamil
  • Also See:
    31163 Drug Screen with Volatiles, Blood
  • Spec Type:
    Serum
  • Spec Container:
    Red top (serum) tube
  • Alt Spec Type:
    Whole blood
  • Alt Spec Container:
    Gray top (fluoride/oxalate) tube
  • Pref Vol:
    3.0 mL
  • Min Vol:
    1.0 mL
  • Fasting:
    No
  • Spec Collect:
    Do not use gel-barrier tubes for specimen collection
    Routine venipuncture
    Note anatomical draw site on specimen label and test request form
  • Spec Process:
    Do not centrifuge
    Do not remove serum or plasma from cells
  • Spec Store Transport:
    Refrigerated
  • Spec Stability:
    1 week refrigerated (2-8°C)
  • Methodology:
    Enzyme Immunoassay (EIA) [Moderate Complexity]
    Gas Chromatography/Mass Spectrometry (GC/MS) [High Complexity]
    Color Spot Tests [Moderate Complexity]
  • Use:
    Detect drug use
    Evaluate toxicity
  • Clinical Significance:
    Drugs or drug metabolites may be detected by a variety of techniques. This procedure utilizes the techniques of Gas Chromatography/Mass Spectrometry (GC/MS), Gas Chromatography (GC), Enzyme Immunoassay (EIA), and color spot tests. The lower limit of detection for most drugs detectable by the procedure ranges from 0.5 to 2.0 mcg/mL. The EIA test is generally more sensitive and may have lower limits of detection. EIA results may be reported as being positive for a drug class, since the EIA technique does not necessarily identify a specific drug (e.g., Opiates). This procedure can detect most drugs of abuse, many prescription drugs, and many over-the-counter medications. Not all drugs are detectable by this procedure. In particular, it should be noted that LSD, insulin, vitamins, and most antibiotics are not detectable by this procedure. This drug test does not utilize forensic procedures. It is intended for medical purposes.
  • Reference Range:

    DRUG SCREEN
    SERUM:    		 
      Serum Drug Sc
        Specimen: SERUM

     In addition to drug screening by GC/MS, color tests (CT),
     and immunoassay (IA) tests are routinely performed.

     Immunoassay and color testing produced the following
     results:

        DRUG
    Benzodiazepine class
    Cocaine metabolite
    Opiate class
    Oxycodone
    THC (marijuana metabolite)     
     
     
    Salicylate
    Acetaminophen    		RESULT
    Negative
    Negative
    Negative
    Negative
    Negative
     
     
    Negative
    Negative    		IA CUTOFF
    100 ng/mL
    100 ng/mL
    100 ng/mL
    100 ng/mL
    10 ng/mL
     
    CT CUTOFF
    50 mcg/mL
    10 mcg/mL
     
        Immunoassay and color test results are not routinely
    confirmed.

    GC/MS screening produced the following results:
                                      No drugs detected

    List of drugs screened for by GC/MS:
    acetaminophen, alprazolam, amitriptyline, amphetamine, amobarbital, brompheniramine, bupropion, butabarbital, butalbital, carbamazepine, carisoprodol, chlordiazepoxide, chlorpheniramine, clomipramine, clonazepam, clorazepate (as nordiazepam), cocaine, codeine, cyclobenzaprine, desalkylflurazepam, dextromethorphan, diazepam, dihydrocodeine, diphenydramine, doxepin, doxylamine, ephedrine/pseudoephedrine, ethosuximide, flurazepam, fluoxetine, glutehimide, hydrocodone, hydromorphone, hydroxyzine, ibuprofen, imipramine, lidocaine, lorazepam, MDA, MDMA, meperidine, meprobamate, methadone, methamphetamine, methaqualone, metoprolol, morphine, NAPA, naproxen, nordiazepam, nortriptyline, oxycodone, pentazocine, pentobarbital, phencyclidine, phenobarbital, phentermine, phenylpropanolamine, phenytoin, primidone, procainamide, promethazine, propoxyphene, pseudophedrine/ephedrine, secobarbital, sertraline, temazepam, theophylline, thioridazine, tramadol, trazodone, trimipramine, tripelennamine, venlafaxine, verapamil.

    Limit of detection for most drugs = 1 mcg/mL.
    Other drugs not listed may be detected and reported.

    To discuss detectability of specific drugs by these procedures or to inquire about the availability of additional quantitative testing for specific drugs, please call the Toxicology laboratory.

  • Day Run:
    Mon-Fri
  • Time Run:
    2:00 pm
  • Time Reported:
    2-5 days
  • Test Type:
    TOX-TDM

Home > Test Directory > Search Results

Test Directory